首页> 外文期刊>Oman Journal of Ophthalmology >Applications of polymers in intraocular drug delivery systems
【24h】

Applications of polymers in intraocular drug delivery systems

机译:聚合物在眼内给药系统中的应用

获取原文
           

摘要

We are entering a new era of ophthalmic pharmacology where new drugs are rapidly being developed for the treatment of anterior and posterior segment of the eye disease. The pharmacokinetics of drug delivery to the eye remains a very active area of ophthalmic research. Intraocular drug delivery systems allow the release of the drug, bypassing the blood–ocular barrier. The main advantage of these preparations is that they can release the drug over a long time with one single administration. These pharmaceutical systems are of great important in the treatment of the posterior segment diseases, and they can be prepared from biodegradable or nonbiodegradable polymers. Biodegradable polymers have the advantage of disappearing from the site of action after releasing the drug. The majority of intraocular devices are prepared from nonbiodegradable polymers, and they can release controlled amounts of drugs for months. Nonbiodegradable polymers include silicone, polyvinyl alcohol, and ethylene-vinyl acetate. The polymers usually employed to prepare nanoparticles for the topical ophthalmic route are poly (acrylic acid) derivatives (polyalquilcyanocrylates), albumin, poly-μ-caprolactone, and chitosan. Dendrimers are a recent class of polymeric materials with unique nanostructure which has been studied to discover their role in the delivery of therapeutics and imaging agents. Hydrogels are polymers that can swell in aqueous solvent system, and they hold the solvents in a swollen cross-linked gel for delivery. This review exhibits the current literature regarding applications of polymers in ophthalmic drug delivery systems including pharmacokinetics, advantages, disadvantages, and indications aimed to obtain successful eye therapy. Method of Literature Search: A systematic literature review was performed using PubMed databases into two steps. The first step was oriented to classification of intraocular polymers implants focusing on their advantages and disadvantages. The second step was focused on the role of polymers therapy for intraocular pathology with clinical examples. The search strategy was not limited by year of publication.
机译:我们正在进入眼药理学的新纪元,在该时代中,正在迅速开发用于治疗眼病的前部和后部的新药。向眼睛递送药物的药代动力学仍然是眼科研究的一个非常活跃的领域。眼内药物输送系统允许药物释放,从而绕过血-眼屏障。这些制剂的主要优点是,一次给药可以长时间释放药物。这些药物系统在后段疾病的治疗中非常重要,它们可以由可生物降解或不可生物降解的聚合物制备。可生物降解的聚合物具有释放药物后从作用部位消失的优点。大多数眼内装置是由不可生物降解的聚合物制成的,它们可以释放受控量的药物达数月之久。不可生物降解的聚合物包括硅酮,聚乙烯醇和乙烯-乙酸乙烯酯。通常用于制备用于局部眼科途径的纳米颗粒的聚合物是聚(丙烯酸)衍生物(聚邻氰基丙烯酸酯),白蛋白,聚-己内酯和壳聚糖。树状聚合物是具有独特的纳米结构的最新一类聚合物材料,已经对其进行研究以发现其在治疗剂和显像剂的递送中的作用。水凝胶是可以在水性溶剂体系中溶胀的聚合物,它们将溶剂保持在溶胀的交联凝胶中以进行递送。这篇综述展示了有关聚合物在眼科药物输送系统中的应用的最新文献,包括药代动力学,优点,缺点和旨在获得成功的眼科治疗的适应症。文献检索方法:使用PubMed数据库将系统的文献综述分为两个步骤。第一步是针对眼内聚合物植入物的分类,重点是它们的优缺点。第二步集中于聚合物治疗在眼内病理学中的作用和临床实例。搜索策略不受发布年份的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号